Impact of Multiple and Long Sirolimus-Eluting Stent Implantation on 3-Year Clinical Outcomes in the j-Cypher Registry

JACC: Cardiovascular Interventions

Volumn 3, Issue 2, 2010, Pages 180-188

  Shirai, Shinichi ^a   Kimura, Takeshi ^b   Nobuyoshi, Masakiyo ^a   Morimoto, Takeshi ^c   Ando, Kenji ^a   Soga, Yoshimitsu ^a   Yamaji, Kyohei ^a   Kondo, Katsuhiro ^a   Sakai, Koyu ^a   Arita, Takeshi ^a   Goya, Masahiko ^a   Iwabuchi, Masashi ^a   Yokoi, Hiroyoshi ^a   Nosaka, Hideyuki ^a   Mitsudo, Kazuaki ^d  

^a KOKURA MEMORIAL HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

clinical outcomes; coronary artery disease; follow up studies; long stent; stent

Indexed keywords

RAPAMYCIN;

AGED; ARTICLE; CORONARY ARTERY RECANALIZATION; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMPLANT REGISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STENT THROMBOSIS;

AGED; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; LOGISTIC MODELS; MALE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK; RISK FACTORS; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 76449085829     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.11.009     Document Type: Article

References (39)

1. Kobayashi Y., De Gregorio J., Kobayashi N., et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 34 (1999) 651-659
2. Kastrati A., Elezi S., Dirschinger J., et al. Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 83 (1999) 1617-1622
3. Colombo A., Goldberg S.L., Almagor Y., et al. A novel strategy for stent deployment in the treatment of acute or threatened closure complicating balloon coronary angioplasty: use of short or standard (or both) single or multiple Palmaz-Schatz stents. J Am Coll Cardiol 22 (1993) 1887-1891
4. Mehran R., Dangas G., Abizaid A.S., et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 10 (1999) 1872-1878
5. Shiran A., Mintz G.S., Waksman R., et al. Early lumen loss after treatment of in-stent restenosis: an intravascular ultrasound study. Circulation 98 (1998) 200-203
6. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
7. Morice M.-C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
8. Schampaert E., Cohen E.A., Schluter M., et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115
9. Schofer J., Schluter M., Gershlick A.H., et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
10. Lemos P.A., Serruys P.W., van Domburg R.T., et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 109 (2004) 190-195
11. Urban P., Gershlick A.H., Guagliumi G., et al. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 113 (2006) 1434-1441
12. Abbott J.D., Voss M.R., Nakamura M., et al. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice. J Am Coll Cardiol 50 (2007) 2029-2036
13. Williams D.O., Abbott J.D., Kip K.E., and DEScover Investigators. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover registry circulation. Circulation 114 (2006) 2154-2162
14. Degertekin M., Arampatzis C.A., Lemos P.A., et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol 93 (2004) 826-829
15. Tsagalou E., Chieffo A., Iakovou I., et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 45 (2005) 1570-1573
16. Kim Y.H., Park S.W., Lee S.W., et al. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation 114 (2006) 2148-2153
17. Kim Y.H., Park S.W., Lee C.W., et al. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent and bare metal stent in the treatment of long coronary lesions. Catheter Cardiovasc Interv 67 (2006) 181-187
18. McFadden E.P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
19. Lagerqvist B., James S.K., Stenestrand U., et al. Longterm outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
20. Daemen J., Wenaweser P., Tsuchida K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
21. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
22. Kimura T., Morimoto T., Nakagawa Y., et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 119 (2009) 987-995
23. Serruys P.W., Unger F., Sousa J.E., et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 (2001) 1117-1124
24. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials. A case for standardized definitions. Circulation 115 (2007) 2344-2351
25. Lee C.W., Park D.W., Lee B.K., et al. Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries. Am J Cardiol 97 (2006) 506-511
26. Kastrati A., Dibra A., Mehilli J., et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 113 (2006) 2293-2300
27. Serruys P.W., Morice M.C., Kappetein A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009) 961-972
28. Tonino P.A., De Bruyne B., Pijls N.H., et al., FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360 (2009) 213-224
29. Wenaweser P., Daemen J., Zwahlen M., et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 52 (2008) 1134-1140
30. Kotani J., Awata M., Nanto S., et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47 (2006) 2108-2111
31. Finn A.V., Joner M., Nakazawa G., et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
32. Nebeker J.R., Virmani R., Bennett C.L., et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 47 (2006) 175-181
33. Gori A.M., Marcucci R., Migliorini A., et al. Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents. J Am Coll Cardiol 52 (2008) 734-739
34. Grines C.L., Bonow R.O., Casey Jr. D.E., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. J Am Coll Cardiol 49 (2007) 734-739
35. Moreno R., Fernandez C., Hernandez R., et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
36. Cutlip D.E., Baim D.S., Ho K.K.L., et al. Stent thrombosis in the modern era. A pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
37. Orlic D., Bonizzoni E., Stankovic G., et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. J Am Coll Cardiol 43 (2004) 1154-1160
38. de la Torre-Hernandez J.M., Alfonso F., Hernandez F., et al. Drug-eluting stent thrombosis. results from the multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivo). J Am Coll Cardiol 51 (2008) 986-990
39. Planer D., Beyar R., Almagor Y., et al. Long-term (>3 years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry). Am J Cardiol 101 (2008) 953-959